Publication and Presentations | UNC Center for Bioethics

Partnering Through It: Confronting the Institutional Challenges Facing Dual-Career Academic Couples.

Torin Monahan, Jill A. Fisher (2023)

Journal of Women and Minorities in Science and Engineering 29(3): 87-101
Your Health is Your Wealth: The Role of Race and Social Inequality in Healthy Individuals’ Participation in Phase I Trials.

Jill A. Fisher (2023)

Presentation for Science Studies Colloquium, University of California - San Diego
Who Participates in Phase I Clinical Trials and What Are Their Motivations for Participation?

Jill A. Fisher (2022)

Presentation
Adverse Events: Understanding US Clinical Trial Participation in the Context of Social Inequalities.

Jill A. Fisher (2022)

Presentation
Adverse Events, Race and Inequality

Jill A. Fisher ()

Presentation
Re-Evaluating Assumptions about Diversity in Medical Research: Who Participates in What Clinical Trials?

Jill A. Fisher (2022)

Presentation
Ethical Criteria for Improved Human Subject Protections in Phase I Healthy Volunteer Trials

Rebecca L. Walker, Douglas MacKay, Margaret Waltz, Anne Drapkin Lyerly, Jill A. Fisher, (2022)

Ethics & Human Research 44(5): 2-21
Who Participates in Phase I Clinical Trials and What Are Their Motivations for Participation?

Jill A. Fisher, (2022)

Presentation
Mission Creep or Mission Lapse? Scientific Review in Research Oversight.

Margaret Waltz, Jill A. Fisher, Rebecca L. Walker (2022)

AJOB Empirical Bioethics Published Online
Pursuing a ‘Normal’ Life of Food: Families’ Experiences of Pediatric Food Allergy Clinical Trials.

Jill A. Fisher ()

Presentation
The Role of Race and Social Inequality in Healthy Individuals’ Participation in Phase I Trials

Jill Fisher (2022)

Presentation
Translational Science: A Survey of US Biomedical Researchers’ Perspectives and Practices

Walker RL, Saylor KW, Waltz M, Fisher JA (2021)

Lab Animal 51(1): 22-35
How Race and Social Inequalities Influence Healthy People’s Paid Participation in FDA-Required Clinical Trials

Jill Fisher, (2021)

Presentation
Phase I Trial Compensation: How Much Do Healthy Volunteers Actually Earn from Clinical Trial Enrollment?

Jill A. Fisher, Lisa McManus, Julianne M. Kalbaugh, Rebecca L. Walker (2021)

Clinical Trails 18(4): 391–397
Biomedical Researchers’ Perceptions of the NIH’s Sex as a Biological Variable Policy for Animal Research: Results from a U.S. National Survey

Margaret Waltz, Katherine W. Saylor, Jill A. Fisher, Rebecca L. Walker (2021)

Journal of Women's Health 30(10): 1395 - 1405
Speculating on Precarious Income: Finance Cultures and the Risky Strategies of Healthy Volunteers in Clinical Drug Trials

Jill A. Fisher, Megan M. Wood, Torin Monahan (2020)

Journal of Cultural Economy Published Online
Evaluating the National Institutes of Health’s Sex as a Biological Variable Policy: Conflicting Accounts from the Front Lines of Animal Research

Margaret Waltz, Jill A. Fisher, Anne Drapkin Lyerly, Rebecca L. Walker (2020)

Journal of Women's Health 30(3): 348 - 354
Healthy Volunteers

Jill Fisher (2020)

in The Oxford Handbook of Research Ethics
Gendered Logics of Biomedical Research: Women in U.S. Phase I Clinical Trials

Marci D. Cottingham, Jill A. Fisher (2020)

Social Problems Published Online
“My Body is One of the Best Commodities”: Exploring the Ethics of Commodification in Phase I Healthy Volunteer Clinical Trials

Rebecca L. Walker, Jill A. Fisher (2020)

Kennedy Institute of Ethics Journal 29(4): 305-331
Sacrificial Labor: Social Inequality, Identity Work, and the Damaging Pursuit of Elusive Futures.

Torin Monahan, Jill A. Fisher (2019)

Work, Employment & Society 34(3): 441-456
Picking and Choosing Among Phase I Trials: A Qualitative Examination of How Healthy Volunteers Understand Study Risks.

Jill A. Fisher, Torin Monahan, Rebecca L. Walker (2019)

Journal of Bioethical Inquiry 16(4): 535-549
Research Payment and Its Social Justice Concerns.

Jill A. Fisher (2019)

American Journal of Bioethics 19(9): 35-36
Commentary on Zvonareva et al.: Exploring the Many Meanings of ‘Professional’ in Research Participation.

Jill A. Fisher (2019)

Clincial Trials Published Online
Appraising Harm in Phase I Trials: Healthy Volunteers’ Accounts of Adverse Events

Lisa McManus, Arlene Davis, Rebecca L. Forcier, Jill A. Fisher (2019)

The Journal of Law, Medicine & Ethics 47(2): 323–333
Advancing Ethics and Policy for Healthy‐Volunteer Research through a Model‐Organism Framework

Jill A. Fisher, Rebecca L. Walker (2019)

Ethics & Human Research 41(1): 4-14
Companion Animal Studies: Slipping Through a Research Oversight Gap

Rebecca L. Walker, Jill A. Fisher (2018)

The American Journal of Bioethics 18(10): 62-63
Healthy volunteers’ perceptions of risk in US Phase I clinical trials: A mixed-methods study

Jill A. Fisher, Lisa McManus, Marci D. Cottingham, Julianne M. Kalbaugh, Megan M. Wood, Torin Monahan, Rebecca L. Walker (2018)

PLoS Medicine 15(11): e1002698
Disadvantaged, Outnumbered, and Discouraged: Women’s Experiences as Healthy Volunteers in U.S. Phase I Trials

Nupur Jain, Marci D. Cottingham, Jill A. Fisher (2018)

Critical Public Health 30(2): 141-152
Healthy Volunteers’ Perceptions of the Benefits of Their Participation in Phase I Clinical Trials

Jill A. Fisher, Lisa McManus, Megan M. Wood, Marci D. Cottingham, Julianne M. Kalbaugh, Torin Monahan, Rebecca L. Walker (2018)

Journal of Empirical Research on Human Research Ethics 13(5): 494-510
To Report or Not to Report: Exploring Healthy Volunteers’ Rationales for Disclosing Adverse Events in Phase I Drug Trials

Lisa McManus, Jill A. Fisher (2018)

AJOB Empirical Bioethics 9(2): 82-90
Captive to the Clinic: Phase I Clinical Trials as Temporal Total Institutions

Quintin Williams, Jill A. Fisher (2018)

Sociological Inquiry 88(4): 724-748
Exceptional Risk: Healthy Volunteers’ Perceptions of HIV/AIDS Clinical Trials

Marci D. Cottingham, Julianne M. Kalbaugh, Teresa Swezey, Jill A. Fisher (2018)
Serial Participation and the Ethics of Phase 1 Healthy Volunteer Research

Rebecca L. Walker, Marci D. Cottingham, Jill A. Fisher (2018)

The Journal of Medicine and Philosophy 43(1): 83-114
Ethics of Treatment Interruption Trials in HIV Cure Research: Addressing the Conundrum of Risk/Benefit Assessment

Gail E. Henderson, Holly L. Peay, Eugene Kroon, Rosemary Jean Cadigan, Karen Meagher, Thidarat Jupimai, Adam Gilbertson, Jill Fisher, Nuchanart Q. Ormsby, Nitiya Chomchey, Nittaya Phanuphak, Jintanat Ananworanich, Stuart Rennie (2017)

Journal of Medical Ethics : medethics-2017-104433
From Fantasy to Reality: Managing Biomedical Risk Emotions In and Through Fictional Media

Marci D. Cottingham, Jill A. Fisher (2017)

Health, Risk & Society 19(5-6): 284-300
Risk and Emotion Among Healthy Volunteers in Clinical Trials

Marci D. Cottingham, Jill A. Fisher (2016)

Social Psychology Quarterly : 0190272516657655
Stem Cell Initiatives as a New Window Into Health Disparities

Jill A. Fisher (2016)

Contemporary Sociology 45(3): 276-278
This Isn’t Going to End Well: Fictional Representations of Medical Research in Television and Film

Jill A. Fisher, Marci D. Cottingham (2016)

Public Understanding of Science
‘I’m Still a Hustler’: Entrepreneurial Responses to Precarity by Participants in Phase I Clinical Trials

Torin Monahan, Jill A. Fisher (2015)

Economy and Society 44(4): 545-566
Consenting to Heteronormativity: Assumptions in Biomedical Research

Marci D. Cottingham, Jill A. Fisher (2015)

About Gender 4(7)
Peering Into the Pharmaceutical “Pipeline”: Investigational Drugs, Clinical Trials, and Industry Priorities

Jill A.Fisher, Marci D. Cottingham, Corey A. Kalbaugh (2015)

Social Science and Medicine 131: 322-330
Feeding and Bleeding: The Institutional Banalization of Risk to Healthy Volunteers in Phase I Pharmaceutical Clinical Trials

Jill A. Fisher (2015)

Science, Technology and Human Values 40(2): 199-226
Using “Clinical Trial Diaries” to Track Patterns of Participation for Serial Healthy Volunteers in U.S. Phase I Studies

Heather B. Edelblute, Jill A. Fisher (2015)

Journal of Empirical Research on Human Research Ethics 10(1): 65-75
Stopped Hearts, Amputated Toes and NASA: Contemporary Legends Among Healthy Volunteers in US Phase I Clinical Trials

Jill A. Fisher (2015)

Sociology of Health and Illness 37(1): 127-142
Tracking the Pharmaceutical Pipeline: Clinical Trials and Global Disease Burden

Marci D. Cottingham, Corey A. Kalbaugh, Jill A. Fisher (2014)

Clinical and Translational Science 7(4): 297-299
Expanding the Frame of “Voluntariness” in Informed Consent: Structural Coercion and the Power of Social and Economic Context

Jill A. Fisher (2013)

Kennedy Institute of Ethics Journal 23(4): 355-379
Strategies for Obtaining Access to Secretive or Guarded Organizations

Torin Monahan, Jill A. Fisher (2014)

Journal of Contemporary Ethnography : 0891241614549834
Bioethics (Re)Considered Introduction: Exploring the Organizational, Social, and Cultural Context of Bioethics

Raymond De Vries, Jill A. Fisher (2013)

Cambridge Quarterly of Healthcare Ethics 22(4): 389–390
Evaluation of Real-Time Location Systems in Their Hospital Contexts

Jill A. Fisher, Torin Monahan (2012)

International Journal of Medical Informatics 81(10): 705-712
Altruism in Clinical Research: Coordinators' Orientation to Their Professional Roles

Jill A. Fisher, Corey A. Kalbaugh (2012)

Nursing Outlook 60(3): 143-148, 148.e1
(Book Review) Drugs for Life: How Pharmaceutical Companies Define Our Health

Jill A. Fisher (2013)

Sociology of Health and Illness 35(4): 645-646
Adjuvant Treatment for Phenylketonuria (PKU)

Mary Louise Lindegren, Shanthi Krishnaswami, Chris Fonnesbeck, Tyler Reimschisel, Jill Fisher, Katie Jackson, Tracy Shields, Nila A Sathe, Melissa L. McPheeters (2012)

Agency for Healthcare Research and Quality (US)
United States Private-Sector Physicians and Pharmaceutical Contract Research: A Qualitative Study

Jill A. Fisher, Corey A. Kalbaugh (2012)

PLoS Medicine 9(7): e1001271
Challenging Assumptions About Minority Participation in US Clinical Research

Jill A. Fisher, Corey A. Kalbaugh (2011)

American Journal of Public Health 101(12): 2217-2222
Surveillance Impediments: Recognizing Obduracy With the Deployment of Hospital Information Systems

Torin Monahan, Jill A. Fisher (2011)

Surveillance and Society 9(1/2): 1-16
Gender and the Science of Difference: Cultural Politics of Contemporary Science and Medicine

Jill A. Fisher (2011)

Rutgers University Press
The “Biosecuritization” of Healthcare Delivery: Examples of Post-9/11 Technological Imperatives

Jill A. Fisher, Torin Monahan (2011)

Social Science and Medicine 72(4): 545-552
(Book Review) Observing Bioethics

Jill A. Fisher (2010)

Contemporary Sociology 39(1): 35-36
Implanting Inequality: Empirical Evidence of Social and Ethical Risks of Implantable Radio-Frequency Identification (RFID) Devices

Torin Monahan, Jill A. Fisher (2010)

International Journal of Technology Assessment in Health Care 26(4): 370-376
Sex, Gender, and Pharmaceutical Politics: From Drug Development to Marketing

Jill A. Fisher, Lorna M. Ronald (2010)

Gender Medicine 7(4): 357-370
Benefits of “Observer Effects”: Lessons From the Field

Torin Monahan, Jill A. Fisher (2010)

Qualitative Research 10(3): 357-376
Re-Inscribing Gender in New Modes of Medical Expertise: The Investigator-Coordinator Relationship in the Clinical Trials Industry

Jill A. Fisher (2010)

Gender, Work, and Organization 17(2): 150-173
Treatment of Overactive Bladder in Women

Katherine E. Hartmann, Melissa L. McPheeters, Daniel H. Biller, Renée M. Ward, J. Nikki McKoy, Rebecca N. Jerome, Sandra R. Micucci, Laura Meints, Jill A. Fisher, Theresa A. Scott, James C. Slaughter, Jeffrey D. Blume (2009)

AHRQ Publication 09-E017

Agency for Healthcare Research and Quality (US)
Institutional Mistrust in the Organization of Pharmaceutical Clinical Trials

Jill A. Fisher (2008)

Medicine, Health Care, and Philosophy 11(4): 403-413
Medical Research for Hire: The Political Economy of Pharmaceutical Clinical Trials

Jill A. Fisher (2009)

Rutgers University Press
Tracking the Social Dimensions of RFID Systems in Hospitals

Jill A. Fisher, Torin Monahan (2008)

International Journal of Medical Informatics 77(3): 176-183
Direct to Consumer Responsibility: Medical Neoliberalism in Pharmaceutical Advertising and Drug Development

Jill A. Fisher, Lorna M. Ronald (2008)

in Patients, Consumers and Civil Society 10: 29-51

Emerald Group Publishing Limited
“Ready-To-Recruit” or “Ready-To-Consent” Populations?: Informed Consent and the Limits of Subject Autonomy

Jill A. Fisher (2007)

Qualitative Inquiry 13(6): 875-894
Practicing Research Ethics: Private-Sector Physicians & Pharmaceutical Clinical Trials

Jill A. Fisher (2008)

Social Science and Medicine 66(12): 2495-2505
Governing Human Subjects Research in the USA: Individualized Ethics and Structural Inequalities

Jill A. Fisher (2007)

Science and Public Policy 34(2): 117-126
(Book Review) the Politics of Personalised Medicine: Pharmacogenetics in the Clinic

Jill A. Fisher (2007)

Critical Sociology 33(1-2): 368-372
Coming Soon to a Physician Near You: Medical Neoliberalism and Pharmaceutical Clinical Trials

Jill A. Fisher (2007)

Harvard Health Policy Review 8(1): 61-70
Procedural Misconceptions and Informed Consent: Insights From Empirical Research on the Clinical Trials Industry

Jill A. Fisher (2006)

Kennedy Institute of Ethics Journal 16(3): 251-268
Co-Ordinating ‘Ethical’ Clinical Trials: The Role of Research Coordinators in the Contract Research Industry

Jill A. Fisher (2006)

Sociology of Health and Illness 28(6): 678-694
(Book Review) Narrating the New Predictive Genetics: Ethics, Ethnography, and Science

Jill A. Fisher (2006)

Critical Sociology 32(4): 717-720
Playing Patient, Playing Doctor: Munchausen Syndrome, Clinical S/M, and Ruptures of Medical Power

Jill A. Fisher (2006)

Journal of Medical Humanities 27(3): 135-149
Investigating the Barons: Narrative and Nomenclature in Munchausen Syndrome

Jill A. Fisher (2006)

Perspectives in Biology and Medicine 49(2): 250-262
Indoor Positioning and Digital Management: Emerging Surveillance Regimes in Hospitals

Jill A. Fisher (2006)

in Surveillance and security: Technological politics and power in everyday life : 77–88

Taylor & Francis